GDF2 and Alzheimer disease: Lopez-Coviella et al. studied mouse medial septum neurons and showed that BMP-9 increases the expression of cholinergic markers in the hippocampus and prevents the loss of choline acetyltransferase (ChAT); this loss is characteristic of AD-associated memory loss11.